Frontiers in PET Molecular Imaging and Molecular Diagnostics
Deadline for manuscript submissions: closed (15 March 2023) | Viewed by 12113
Interests: PET/CT; SPECT/CT; molecular imaging; nuclear cardiology; atherosclerosis; radiomics
Special Issues, Collections and Topics in MDPI journals
The relevance of multiple causes of disease development, progression and treatment response is widely recognized in complex diseases. Integration of two disciplines of molecular imaging and molecular medicine (eg. genomics, proteomics), following a systems-biology approach become an emerging strategy that enables the noninvasive visualization, characterization, and quantification of molecular signatures and processes within living objectives in clinical practice. Positron emission tomography (PET) molecular imaging, stands out as a platform for advanced, noninvasive probing of metabolic and signaling pathways on a cellular, organ, or cross-organ level.
PET molecular imaging normally encompasses radiology and nuclear medicine and it is helpful for disease screening, early diagnosis, evaluation of disease location and expending, and prognosis. Its applications are essential to support the selection of therapy and evaluate the therapy response and follow-up. Joint PET molecular imaging and molecular diagnostics can be used to improve diagnostic work-up and therapeutic decision-making to the redefined molecular lesions with targeted therapy.
In the last decade, we have witnessed the development and combination of radiotracers and targeted radiopharmaceuticals which can map the disease within a patient and guide subsequently targeted radionuclide treatment, particularly in the era of personalized medicine. An array of technical and methodological approaches that entail imaging data analysis, advanced machine learning/deep learning, bioinformatics, radiomics, and interactomics analysis in PET molecular imaging provide insights into selected signaling. In turn, they could expand our understanding of the various pathomechanisms and help us consolidate an appreciation for a systemic approach to precision medicine.
For this Special Issue, we encourage all topics relevant to PET molecular imaging and molecular diagnostics. We accept reviews, original research (both clinical and preclinical), and brief communications.
Prof. Dr. Xiang Li
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- PET molecular imaging
- molecular diagnostics
- artificial intelligence
- liquid biopsy